Inmunoterapia & Hemopatías 2021

Registration

Status

Activity finished

Price

Free

Do you want to know the next activities activities on hemopathology? Sign up to our newsletter list to be updated on upcoming activities.

Information

The third edition of the conference “Immunotherapy and Hemopathies” aims to update on diagnostic aspects using new molecular techniques and imaging tests, as well as on the prognosis and new treatment options in different malignant hemopathies.

The third edition of the conference “Immunotherapy and Hemopathies” aims to update on diagnostic aspects using new molecular techniques and imaging tests, as well as on the prognosis and new treatment options in different malignant hemopathies.

Program:

• Download program

Documents:

• Segunda línea: Linfomas (Hodgkin y no hodgkiniano)
• Mieloma
• Linfoma No Hodgkin (LNH)
• Tercera línea: Mieloma
• Primera línea: Leucemia Aguda Linfoblástica (LAL)
• Leucemias Y linfomas T
• Leucemia Aguda Linfoblástica (LAL)

Coordinators

• 

  Josep Mª Ribera

  Head of the Haematology Department at ICO Badalona

  Hospital Universitari Germans Trias i Pujol, Badalona.

  

  Josep Mª Ribera

  Head of the Haematology Department at ICO Badalona

  Coordinator of the Acute Lymphoblastic Leukaemia Group of the Spanish Haematology Treatment Programme (LALPETHEMA) of the Spanish Society of Haematology and Haemotherapy (SEHH), and head of the Haematology and Haemotherapy Department of the ICO-Hospital Germans Trias i Pujol (Badalona).

Accreditation

Activity accredited by Consell Català de Formació Continuada de les Professions Sanitàries Comisión de Formación Continuada del Sistema Nacional de Salud with 0,8 credits and register number: 09/029964-MD

• 
•